"Firma MTZ Clinical Research Sp. z o. o. (MTZ) Poddawana inspekcjom firma prowadząca badania kliniczne na zlecenie (CRO) posiadająca własny kliniczny ośrodek badawczy Skupia się na rozwoju badań klinicznych we wczesnej fazie oraz badaniach nad biorównoważnością Oferuje pełen zakres usług Założona w 2002 r."

During the past decade, MTZ Clinical Research Sp. z o.o. conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 31 clinical trials were completed, i.e. on average, 79.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MTZ Clinical Research Sp. z o.o." #1 sponsor was "Pfizer" with 18 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Takeda" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Philip Morris Products S.A." with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MTZ Clinical Research Sp. z o.o." #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "MTZ Clinical Research Sp. z o.o." are "Psoriasis" (5 trials), "Dermatitis, Atopic" (4 trials), "Atopic Dermatitis" (3 trials), "Rheumatoid Arthritis" (3 trials) and "Chronic Plaque Psoriasis" (2 trials). Many other conditions were trialed in "MTZ Clinical Research Sp. z o.o." in a lesser frequency.

Most popular intervention types in "MTZ Clinical Research Sp. z o.o." are "Drug" (44 trials), "Biological" (7 trials), "Other" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "CP-690,550" (3 trials), "PF-04965842 100 mg" (3 trials), "PF-04965842 200 mg" (3 trials) and "PF-06700841" (3 trials). Other intervention names were less common.

The vast majority of trials in "MTZ Clinical Research Sp. z o.o." are 49 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MTZ Clinical Research Sp. z o.o.". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in MTZ Clinical Research Sp. z o.o., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in MTZ Clinical Research Sp. z o.o., 6 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".